P A Friedman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P A Friedman

Showing results (161-170 of 187) with videos related to

Pageof 19

Sort By:

The Journal of Biological Chemistry|May 25, 1990

Partial purification and characterization of bovine liver aspartyl beta-hydroxylaseR S Gronke, D J Welsch, W J VanDusen, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987

Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domainsC T Przysiecki, J E Staggers, H G Ramjit, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989

Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IXR S Gronke, W J VanDusen, V M Garsky, et al.

Pacing and Clinical Electrophysiology : PACE|January 31, 2002

Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncopeE S Brilakis, W K Shen, S C Hammill, et al.

Neuroradiology|January 1, 1992

Multiple sclerosis masquerading as a mass lesionD W Giang, K R Poduri, T A Eskin, et al.

The American Journal of Physiology|April 13, 1999

Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTHW Yang, P A Friedman, R Kumar, et al.

The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998

Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3S A Mousa, J M Bozarth, W Lorelli, et al.

The Journal of Biological Chemistry|July 15, 1992

cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylaseS Jia, W J VanDusen, R E Diehl, et al.

Biochemical and Biophysical Research Communications|November 30, 1992

Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modulesD D Monkovic, W J VanDusen, C J Petroski, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989

Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogsV M Garsky, P K Lumma, R M Freidinger, et al.

Pageof 19

Search research articles

Showing results (161-170 of 187) with videos related to

Sort By:

Pageof 19

The Journal of Biological Chemistry|May 25, 1990

Partial purification and characterization of bovine liver aspartyl beta-hydroxylaseR S Gronke, D J Welsch, W J VanDusen, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987

Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domainsC T Przysiecki, J E Staggers, H G Ramjit, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989

Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IXR S Gronke, W J VanDusen, V M Garsky, et al.

Pacing and Clinical Electrophysiology : PACE|January 31, 2002

Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncopeE S Brilakis, W K Shen, S C Hammill, et al.

Neuroradiology|January 1, 1992

Multiple sclerosis masquerading as a mass lesionD W Giang, K R Poduri, T A Eskin, et al.

The American Journal of Physiology|April 13, 1999

Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTHW Yang, P A Friedman, R Kumar, et al.

The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998

Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3S A Mousa, J M Bozarth, W Lorelli, et al.

The Journal of Biological Chemistry|July 15, 1992

cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylaseS Jia, W J VanDusen, R E Diehl, et al.

Biochemical and Biophysical Research Communications|November 30, 1992

Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modulesD D Monkovic, W J VanDusen, C J Petroski, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989

Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogsV M Garsky, P K Lumma, R M Freidinger, et al.

Pageof 19